Cboe CA - Delayed Quote CAD
NOVARTIS CDR (CAD HEDGED) (NVS.NE)
21.68
+0.25
+(1.17%)
At close: April 24 at 11:30:54 AM EDT
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
17,619,000
17,619,000
14,458,000
14,236,000
15,071,000
Investing Cash Flow
-7,513,000
-7,513,000
5,596,000
1,468,000
4,208,000
Financing Cash Flow
-11,742,000
-11,742,000
-14,278,000
-20,562,000
-16,264,000
End Cash Position
11,459,000
11,459,000
13,393,000
7,517,000
12,407,000
Capital Expenditure
-3,814,000
-3,814,000
-2,753,000
-2,239,000
-2,556,000
Issuance of Debt
7,101,000
7,101,000
546,000
252,000
16,000
Repayment of Debt
-2,711,000
-2,711,000
-2,481,000
-2,837,000
-5,987,000
Repurchase of Capital Stock
-8,331,000
-8,331,000
-8,719,000
-10,652,000
-3,057,000
Free Cash Flow
13,805,000
13,805,000
11,705,000
11,997,000
12,515,000
12/31/2021 - 2/24/2025
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
ROG.NE Roche Holding AG
20.82
+2.36%
NVON.NE NOVO NORDISK CDR (CAD HEDGED)
6.73
+2.75%
PFIZER.NS Pfizer Limited
4,186.00
-2.10%
JNJ.NE JOHNSON & JOHNSON CDR (CAD HEDG
20.44
-0.20%
PFE.NE Pfizer Inc.
10.50
+2.24%
LLY.NE Eli Lilly and Company
31.75
+3.66%
RHHBY Roche Holding AG
39.75
+0.03%
AZN AstraZeneca PLC
69.55
+1.52%
MRK Merck & Co., Inc.
79.84
+1.40%
JNJ Johnson & Johnson
154.93
-0.29%